ClinicalTrials.Veeva

Menu

Correlation Between the Visual Acuity & the OCT Pattern of Macular Edema Secondary to RVO

A

Assiut University

Status

Unknown

Conditions

Retinal Vein Occlusion

Treatments

Device: OCT

Study type

Observational

Funder types

Other

Identifiers

NCT03489915
cbtvaatoctpomestrvo

Details and patient eligibility

About

Correlation between changes observed in OCT and VA in patients with retinal vein occlusion whether the patient's VA improves when macular edema improves in OCT or not ??

Full description

Central retinal vein occlusion (CRVO) is a common retinal vascular disorder. Clinically, CRVO presents with variable visual loss; fundus may show retinal hemorrhages, dilated tortuous retinal veins, cotton-wool spots, macular edIn view of the devastating complications associated with the severe form of CRVO, number of classifications were described. All of classifications take into account the area of retinal capillary nonperfusion and development of neovascular complications.

CRVO can be divided into 2 clinical types, ischemic and nonischemic. In addition, a number of patients may have an intermediate presentation with variable clinical course. On initial presentation, it may be difficult to classify a given patient, since CRVO may change with time.

A number of clinical and ancillary investigative factors are taken into account for classifying CRVO:

Nonischemic CRVO is milder form of disease. It may present with good vision, few retinal hemorrhages and cotton-wool spots, no relative afferent pupillary defect, and good perfusion to the retina. Nonischemic CRVO may resolve fully with good visual outcome or may progress to the ischemic type.

Ischemic CRVO is the severe form of the disease. CRVO may present initially as the ischemic type, or it may progress from nonischemic. Usually, ischemic CRVO presents with severe visual loss, extensive retinal hemorrhages and cotton-wool spots, presence of relative afferent pupillary defect, poor perfusion to retina, and presence of severe electroretinographic changes. In addition, patients may end up with neovascular glaucoma and a painful blind eye.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with macular edema related to vein occlusion .
  • Patient's Age above 18 years old .
  • Patients able to sit on OCT device .

Exclusion criteria

  • Significant cataract .
  • Media opacities as vitreous haemorrhage .
  • patients with macular edema related to CRVO treated by laser photocoagulation .
  • patients with glaucoma .
  • Patients with chronic uveitis.

Trial design

30 participants in 1 patient group

Patients with macular edema due to RVO
Description:
assessment of visual acuity using Landolt chart and follow up of macular edema using OCT
Treatment:
Device: OCT

Trial contacts and locations

0

Loading...

Central trial contact

waleed s Mohamed, lecturer; Samir Y Saleh, professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems